(0.06%) 5 472.70 points
(0.10%) 39 150 points
(0.39%) 17 786 points
(0.07%) $80.89
(-3.66%) $2.66
(-0.79%) $2 312.30
(0.16%) $28.92
(3.52%) $1 021.10
(0.28%) $0.936
(0.69%) $10.68
(0.44%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases...
Stats | |
---|---|
今日成交量 | 2 459 |
平均成交量 | 4 545 |
市值 | 1.77B |
EPS | $-1.140 ( Q1 | 2024-05-08 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.329 (3.37%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-04 | Lewis William | Buy | 100 000 | Option (right to buy) |
2024-01-04 | Lewis William | Buy | 0 | |
2024-01-01 | Kooij Louise Frederika | Buy | 150 494 | Option (right to buy) |
2024-01-01 | Kling Douglas F | Buy | 323 771 | Option (right to buy) |
2024-01-01 | Van Der Kamp Hilde Johanna | Buy | 10 000 | Option (right to buy) |
INSIDER POWER |
---|
-60.42 |
Last 28 transactions |
Buy: 2 224 204 | Sell: 9 064 754 |
NewAmsterdam Pharma 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
NewAmsterdam Pharma 财务报表
Annual | 2023 |
营收: | $14.09M |
毛利润: | $14.05M (99.68 %) |
EPS: | $-2.15 |
FY | 2023 |
营收: | $14.09M |
毛利润: | $14.05M (99.68 %) |
EPS: | $-2.15 |
FY | 2022 |
营收: | $97.50M |
毛利润: | $97.43M (99.93 %) |
EPS: | $-7.85 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
NewAmsterdam Pharma
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。